116 related articles for article (PubMed ID: 7040200)
1. The relationship between prostacyclin activity and pressure in the portal vein.
Hamilton G; Phing RC; Hutton RA; Dandona P; Hobbs KE
Hepatology; 1982; 2(2):236-42. PubMed ID: 7040200
[TBL] [Abstract][Full Text] [Related]
2. Portal vein prostacyclin activity in experimental portal hypertension in rats.
Hamilton G; Rosza I; Hutton R; Chow FP; Dandona P; Hobbs KE
Clin Sci (Lond); 1981 Mar; 60(3):327-9. PubMed ID: 7016407
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
Sitzmann JV; Campbell K; Wu Y; St Clair C
Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
[TBL] [Abstract][Full Text] [Related]
4. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: evidence for effects on protein kinase C and calcium.
Jeremy JY; Mikhailidis DP; Karatapanis S; Harry D; Burroughs AK; McIntyre N; Stansby G; Jacobs M; McCormick A
J Hepatol; 1994 Dec; 21(6):1017-22. PubMed ID: 7699222
[TBL] [Abstract][Full Text] [Related]
5. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
6. The role of prostacyclin in patients with portal hypertension.
Hashizume M; Inokuchi K; Tanaka K
Liver; 1985 Apr; 5(2):89-93. PubMed ID: 3889532
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of overproduction of plasma prostacyclin in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Jiao Z; Chen Z; Kuang Y
Chin Med J (Engl); 1998 Dec; 111(12):1064-7. PubMed ID: 11263364
[TBL] [Abstract][Full Text] [Related]
8. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Yin J; Leng X; Zhu J
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
[TBL] [Abstract][Full Text] [Related]
9. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
13. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
14. Systemic and portal prostacyclin and thromboxane response to hemorrhage in portal hypertension.
Wu Y; Burns C; Campbell KA; Sitzmann JV
Shock; 1994 Jul; 2(1):68-71. PubMed ID: 7735986
[TBL] [Abstract][Full Text] [Related]
15. Diminished urinary prostacyclin metabolite in essential hypertension.
Grose JH; Lebel M; Gbeassor FM
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():121s-123s. PubMed ID: 7004719
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
Rosenkranz B; Fischer C; Reimann I; Weimer KE; Beck G; Frölich JC
Artery; 1980; 8(1):18-22. PubMed ID: 7000039
[TBL] [Abstract][Full Text] [Related]
17. Portal hemodynamics and humoral factors involved in a portal hypertensive rabbit model.
Lin PW; Shan YS
Proc Natl Sci Counc Repub China B; 1995 Oct; 19(4):240-5. PubMed ID: 8742622
[TBL] [Abstract][Full Text] [Related]
18. Effect of portosystemic shunting on PGI2 and glucagon levels in humans.
Sitzmann JV; Campbell KA; Wu Y; Cameron JL
Ann Surg; 1993 Mar; 217(3):248-52. PubMed ID: 8452403
[TBL] [Abstract][Full Text] [Related]
19. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
Sitzmann JV; Li SS; Adkinson NF
Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
[TBL] [Abstract][Full Text] [Related]
20. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination.
Guarner C; Soriano G; Such J; Teixidó M; Ramis I; Bulbena O; Roselló J; Guarner F; Gelpi E; Balanzó J
Gastroenterology; 1992 Jan; 102(1):303-9. PubMed ID: 1727763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
